[NF-kappaB inhibitor].
Department of Urology, Tokyo Medical University.
Jun
J
Nakashima
Yutaka
Y
Horiguchi
Yoshio
Y
Ohno
Tatsuo
T
Gondo
Hisashi
H
Takeuchi
Masaaki
M
Tachibana
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D003512:Cyclohexanones / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D061988:Proteasome Inhibitors; D011759:Pyrrolidines / Q000627:therapeutic use; D013859:Thiocarbamates / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D003512:Cyclohexanones; D005938:Glucocorticoids; D016328:NF-kappa B; D061988:Proteasome Inhibitors; D011759:Pyrrolidines; D013859:Thiocarbamates; C464444:dehydroxymethylepoxyquinomicin; C020972:pyrrolidine dithiocarbamic acid